Similar articles

• Role of beta 2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease.

  Dueymes M, Piette JC, Le Tonquèze M, Bendaoud B, Roué R, Garré M, Youinou P. Dueymes M, et al. Lupus. 1995 Dec;4(6):477-81. doi: 10.1177/096120339500400610. Lupus. 1995. PMID: 8749571
• Antiphospholipid antibodies: involvement of protein cofactors.

  Galli M, Barbui T, Zwaal RF, Comfurius P, Bevers EM. Galli M, et al. Haematologica. 1993 Jan-Feb;78(1):1-4. Haematologica. 1993. PMID: 8491417 No abstract available.
• Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.

  Gharavi AE, Sammaritano LR, Bovastro JL Jr, Wilson WA. Gharavi AE, et al. J Lab Clin Med. 1995 Jun;125(6):775-8. J Lab Clin Med. 1995. PMID: 7769372
• Autoimmune antiphospholipid antibodies: what is their true target?

  Pengo V, Biasiolo A, Fior MG. Pengo V, et al. Haematologica. 1995 Mar-Apr;80(2 Suppl):127-30. Haematologica. 1995. PMID: 7628765 Review. No abstract available.
• [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction].

  Forastiero RR, Martinuzzo ME, Carreras LO. Forastiero RR, et al. Sangre (Barc). 1999 Jun;44(3):223-30. Sangre (Barc). 1999. PMID: 10481585 Review. Spanish. No abstract available.